As a circulating biomarker, PTHrP (12–48) is significantly associated with breast cancer bone metastasis and locally regulates the differentiation of hematopoietic cells and the activity of osteoclasts in the tumor–bone marrow microenvironment, to promote tumor bone metastasis [109]. The gene discussed is PTHLH; the disease is neoplasm.